International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

被引:31
作者
Terrault, Norah A. [1 ]
Berenguer, Marina [2 ,3 ,4 ]
Strasser, Simone I. [5 ]
Gadano, Adrian [6 ]
Lilly, Les [7 ]
Samuel, Didier [8 ]
Kwo, Paul Y. [9 ]
Agarwal, Kosh [10 ]
Curry, Michael P. [11 ]
Fagiuoli, Stefano [12 ]
Fung, James Y. Y. [13 ]
Gane, Edward [14 ]
Brown, Kimberly A. [15 ]
Burra, Patrizia [16 ]
Charlton, Michael [17 ]
Pessoa, Mario G. [18 ]
McCaughan, Geoff W. [19 ]
机构
[1] Univ Calif San Francisco, Hepatol & Transplant Surg, San Francisco, CA 94143 USA
[2] Univ Valencia, Hosp Univ La Fe, Liver Unit, Valencia, Spain
[3] Univ Valencia, Politecn La Fe, Liver Unit, Valencia, Spain
[4] CIBEREHD, Valencia, Spain
[5] Univ Sydney, Royal Prince Alfred Hosp, Australian Natl Liver Transplant Unit, Sydney, NSW, Australia
[6] Hosp Italiano Buenos Aires, Liver Unit, Buenos Aires, DF, Argentina
[7] Toronto Gen Hosp, Univ Hlth Network, Multiorgan Transplant, Toronto, ON, Canada
[8] Univ Paris Saclay, Univ Paris Sud, Ctr Hepatobiliaire, Hop Paul Brousse,AP HP,Hepatol, Villejuif, France
[9] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA
[10] Kings Coll Hosp London, Inst Liver Studies, London, England
[11] Beth Israel Deaconess Med Ctr, Ctr Liver, Boston, MA 02215 USA
[12] Papa Giovanni XXIII Hosp, Gastroenterol & Transplant Hepatol, Begamo, Italy
[13] Queen Mary Hosp, Liver Transplant Ctr, Hong Kong, Hong Kong, Peoples R China
[14] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand
[15] Henry Ford Hosp, Div Gastroenterol & Hepatol, Detroit, MI 48202 USA
[16] Padova Univ Hosp, Dept Surg Oncol & Gastroenterol, Multivisceral Transplant Unit, Padua, Italy
[17] Utah Intermt Transplant & Regenerat Med Ctr, Salt Lake City, UT USA
[18] Univ Sao Paulo, Div Gastroenterol & Hepatol, Sch Med, Sao Paulo, Brazil
[19] Univ Sydney, Centenary Res Inst, Royal Prince Alfred Hosp, Australian Natl Liver Transplant Unit, Sydney, NSW, Australia
关键词
FIBROSING CHOLESTATIC HEPATITIS; VIRUS GENOTYPE 1; SOFOSBUVIR-BASED TREATMENT; ANTIVIRAL THERAPY; LEDIPASVIR-SOFOSBUVIR; COINFECTED PATIENTS; ACTING ANTIVIRALS; DRUG-INTERACTIONS; INFECTED PATIENTS; RIBAVIRIN;
D O I
10.1097/TP.0000000000001704
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:956 / 967
页数:12
相关论文
共 69 条
[1]  
Agarwal K, 2017, EASL
[2]   Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials [J].
Alqahtani, Saleh A. ;
Afdhal, Nezam ;
Zeuzem, Stefan ;
Gordon, Stuart C. ;
Mangia, Alessandra ;
Kwo, Paul ;
Fried, Michael ;
Yang, Jenny C. ;
Ding, Xiao ;
Pang, Phillip S. ;
McHutchison, John G. ;
Pound, David ;
Reddy, K. Rajender ;
Marcellin, Patrick ;
Kowdley, Kris V. ;
Sulkowski, Mark .
HEPATOLOGY, 2015, 62 (01) :25-30
[3]   EFFICACY OF SOFOSBUVIR-BASED TREATMENT REGIMENS IN HIV/HCV CO-INFECTED PATIENTS AFTER LIVER TRANSPLANTATION: THE ANRS CO23 CUPILT STUDY [J].
Antonini, T. M. ;
Coilly, A. ;
Radenne, S. ;
Veislinger, A. ;
Botta-Fridlund, D. ;
Durand, F. ;
Houssel-Debry, P. ;
Kamar, N. ;
Canva, V. ;
Perre, P. ;
Bertucci, I. ;
Dumortier, J. ;
Leroy, V. ;
Samuel, D. ;
Pageaux, G. -P. ;
Duclos-Vallee, J. -C. .
JOURNAL OF HEPATOLOGY, 2015, 62 :S635-S636
[4]   Fibrosing Cholestatic Hepatitis in HIV/HCV Co-Infected Transplant Patients-Usefulness of Early Markers After Liver Transplantation [J].
Antonini, T. M. ;
Sebagh, M. ;
Roque-Afonso, A. M. ;
Teicher, E. ;
Roche, B. ;
Sobesky, R. ;
Coilly, A. ;
Vaghefi, P. ;
Adam, R. ;
Vittecoq, D. ;
Castaing, D. ;
Samuel, D. ;
Duclos-Vallee, J. -C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (08) :1686-1695
[5]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[6]   Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection [J].
Badri, Prajakta S. ;
Parikh, Apurvasena ;
Coakley, Eoin P. ;
Ding, Bifeng ;
Awni, Walid M. ;
Dutta, Sandeep ;
Menon, Rajeev M. .
THERAPEUTIC DRUG MONITORING, 2016, 38 (05) :640-645
[7]   Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation [J].
Berenguer, M. ;
Palau, A. ;
Aguilera, V. ;
Rayon, J. -M. ;
Juan, F. S. ;
Prieto, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) :679-687
[8]   Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].
Berenguer, M ;
Prieto, M ;
Rayón, JM ;
Mora, J ;
Pastor, M ;
Ortiz, V ;
Carrasco, D ;
San Juan, F ;
Burgueño, MDJ ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2000, 32 (04) :852-858
[9]   HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].
Berenguer, M ;
Ferrell, L ;
Watson, J ;
Prieto, M ;
Kim, M ;
Rayón, M ;
Córdoba, J ;
Herola, A ;
Ascher, N ;
Mir, J ;
Berenguer, J ;
Wright, TL .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684
[10]   Survival Benefit of Repeat Liver Transplantation in the United States: A Serial MELD Analysis by Hepatitis C Status and Donor Risk Index [J].
Biggins, S. W. ;
Gralla, J. ;
Dodge, J. L. ;
Bambha, K. M. ;
Tong, S. ;
Baron, A. E. ;
Inadomi, J. ;
Terrault, N. ;
Rosen, H. R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (11) :2588-2594